{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:50:35Z","timestamp":1791931835280,"version":"4.3.4"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319131498","type":"print"},{"value":"9783319131504","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-13150-4_9","type":"book-chapter","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T02:05:53Z","timestamp":1423188353000},"page":"227-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Management of the Marginal Zone Lymphomas"],"prefix":"10.1007","author":[{"given":"Barbara","family":"Vannata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Stathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,7]]},"reference":[{"key":"9_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon"},{"issue":"12","key":"9_CR2","first-page":"1134","volume":"25","author":"F Bertoni","year":"2011","unstructured":"Bertoni F, Coiffier B, Salles G, Stathis A, Traverse-Glehen A, Thieblemont C et al (2011) MALT lymphomas: pathogenesis can drive treatment. Oncology 25(12):1134\u20131142 47","journal-title":"Oncology"},{"issue":"3","key":"9_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","volume":"115","author":"VJ Craig","year":"2010","unstructured":"Craig VJ, Arnold I, Gerke C, Huynh MQ, Wundisch T, Neubauer A et al (2010) Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 115(3):581\u2013591. doi:10.1182\/blood-2009-06-228015","journal-title":"Blood"},{"issue":"2","key":"9_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0046-8177(00)80233-6","volume":"31","author":"E Roggero","year":"2000","unstructured":"Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E et al (2000) Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 31(2):263\u2013268","journal-title":"Hum Pathol"},{"issue":"8","key":"9_CR5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","volume":"96","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell\u2019Oro S, Fleischhauer K et al (2004) Evidence for an association between chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96(8):586\u2013594","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"9_CR6","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1200\/jco.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F et al (2012) Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol 30(24):2988\u20132994. doi:10.1200\/jco.2011.41.4466","journal-title":"J Clin Oncol"},{"issue":"5","key":"9_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/annonc\/mdm513","volume":"19","author":"AJM Ferreri","year":"2008","unstructured":"Ferreri AJM, Dolcetti R, Du MQ, Doglioni C, Giordano Resti A, Politi LS et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19(5):835\u2013846. doi:10.1093\/annonc\/mdm513","journal-title":"Ann Oncol"},{"issue":"3","key":"9_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F et al (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350(3):239\u2013248","journal-title":"N Engl J Med"},{"issue":"2","key":"9_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347(2):89\u201394","journal-title":"N Engl J Med"},{"issue":"1","key":"9_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","volume":"100","author":"L Arcaini","year":"2004","unstructured":"Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E et al (2004) Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 100(1):107\u2013115","journal-title":"Cancer"},{"issue":"2","key":"9_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/annonc\/mdl388","volume":"18","author":"L Arcaini","year":"2007","unstructured":"Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F et al (2007) Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 18(2):346\u2013350. doi:10.1093\/annonc\/mdl388","journal-title":"Ann Oncol"},{"issue":"6","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/annonc\/mdp454","volume":"21","author":"M Paulli","year":"2010","unstructured":"Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F et al (2010) Subcutaneous \u2018lipoma-like\u2019 B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Ann Oncol 21(6):1189\u20131195. doi:10.1093\/annonc\/mdp454","journal-title":"Ann Oncol"},{"issue":"1","key":"9_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2004.04993.x","volume":"126","author":"A Ambrosetti","year":"2004","unstructured":"Ambrosetti A, Zanotti R, Pattaro C, Lenzi L, Chilosi M, Caramaschi P et al (2004) Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 126(1):43\u201349","journal-title":"Br J Haematol"},{"issue":"8","key":"9_CR14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","volume":"4","author":"PG Isaacson","year":"2004","unstructured":"Isaacson PG, Du MQ (2004) MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4(8):644\u2013653","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"9_CR15","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","volume":"109","author":"PJ Jost","year":"2007","unstructured":"Jost PJ, Ruland J (2007) Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences and therapeutic implications. Blood 109(7):2700\u20132707","journal-title":"Blood"},{"issue":"1","key":"9_CR16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI27476","volume":"116","author":"F Bertoni","year":"2006","unstructured":"Bertoni F, Zucca E (2006) Delving deeper into MALT lymphoma biology. J Clin Investig 116(1):22\u201326","journal-title":"J Clin Investig"},{"key":"9_CR17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800670200","author":"FD Langel","year":"2008","unstructured":"Langel FD, Jain NA, Rossman JS, Kingeter LM, Kashyap AK, Schaefer BC (2008) Multiple protein domains mediate interaction between Bcl10 and MALT1. J Biol Chem. doi:10.1074\/jbc.M800670200","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"9_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1242\/jcs.00904","volume":"117","author":"PC Lucas","year":"2004","unstructured":"Lucas PC, McAllister-Lucas LM, Nunez G (2004) NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 117(Pt 1):31\u201339","journal-title":"J Cell Sci"},{"issue":"10","key":"9_CR19","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-05-4590","volume":"66","author":"M Baens","year":"2006","unstructured":"Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al (2006) Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 66(10):5270\u20135277","journal-title":"Cancer Res"},{"key":"9_CR20","doi-asserted-by":"crossref","unstructured":"Novak U, Rinaldi A, Kwee I, Murty VV, Nandula SV, Rancoita PMV et al. (2008) The NF-kB pathway component A20 (TNFAIP3) is commonly inactivated by DNA mutations and deletions in extranodal marginal zone B-cell lymphoma (EMZL). Ann Oncol abstract at the 10-ICML","DOI":"10.1182\/blood.V112.11.299.299"},{"issue":"7","key":"9_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3324\/haematol.2011.040402","volume":"96","author":"I Kwee","year":"2011","unstructured":"Kwee I, Rancoita PM, Rinaldi A, Ferreri AJ, Bhagat G, Gascoyne RD et al (2011) Genomic profiles of MALT lymphomas: variability across anatomical sites. Haematologica 96(7):1064\u20131066. doi:10.3324\/haematol.2011.040402","journal-title":"Haematologica"},{"key":"9_CR22","doi-asserted-by":"publisher","unstructured":"Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto M (2013) Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(6):vi144\u2013vi148. doi:10.1093\/annonc\/mdt343","DOI":"10.1093\/annonc\/mdt343"},{"key":"9_CR23","first-page":"214","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Chott A, Nakamura S, Muller-Hermelink HK, Harris NL, Swerdlow S (2008) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 214\u2013217"},{"issue":"4","key":"9_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/annonc\/mds643","volume":"24","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O et al (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 24(4):857\u2013877. doi:10.1093\/annonc\/mds643","journal-title":"Ann Oncol"},{"issue":"7","key":"9_CR25","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","volume":"101","author":"V Franco","year":"2003","unstructured":"Franco V, Florena AM, Iannitto E (2003) Splenic marginal zone lymphoma. Blood 101(7):2464\u20132472","journal-title":"Blood"},{"issue":"3","key":"9_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","volume":"22","author":"E Matutes","year":"2008","unstructured":"Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A et al (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22(3):487\u2013495","journal-title":"Leukemia"},{"issue":"7","key":"9_CR27","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101(7):2489\u20132495","journal-title":"Blood"},{"issue":"2","key":"9_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3324\/haematol.11835","volume":"93","author":"JP de Boer","year":"2008","unstructured":"de Boer JP, Hiddink RF, Raderer M, Antonini N, Aleman BMP, Boot H et al (2008) Dissemination patterns in non-gastric MALT lymphoma. Haematologica 93(2):201\u2013206. doi:10.3324\/haematol.11835","journal-title":"Haematologica"},{"key":"9_CR29","first-page":"60","volume-title":"MALT lymphomas","author":"C Thieblemont","year":"2004","unstructured":"Thieblemont C, Coiffier B (2004) MALT lymphoma: sites of presentations, clinical features and staging procedures. In: Zucca E, Bertoni F (eds) MALT lymphomas. Landes Bioscience\/Kluwer Academic, Georgetown, pp 60\u201380"},{"issue":"19","key":"9_CR30","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","volume":"24","author":"M Raderer","year":"2006","unstructured":"Raderer M, Wohrer S, Streubel B, Troch M, Turetschek K, Jager U et al (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24(19):3136\u20133141","journal-title":"J Clin Oncol"},{"issue":"1","key":"9_CR31","first-page":"86","volume":"28","author":"E Zucca","year":"2014","unstructured":"Zucca E, Stathis A, Bertoni F (2014) The management of nongastric MALT lymphomas. Oncology 28(1):86\u201393","journal-title":"Oncology"},{"issue":"2","key":"9_CR32","first-page":"194","volume":"26","author":"C Thieblemont","year":"2012","unstructured":"Thieblemont C, Davi F, Noguera ME, Briere J, Bertoni F, Zucca E et al (2012) Splenic marginal zone lymphoma: current knowledge and future directions. Oncology 26(2):194\u2013202","journal-title":"Oncology"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"638185","DOI":"10.1155\/2012\/638185","volume":"2012","author":"L Arcaini","year":"2012","unstructured":"Arcaini L, Merli M, Volpetti S, Rattotti S, Gotti M, Zaja F (2012) Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Clin dev immunol 2012:638185. doi:10.1155\/2012\/638185","journal-title":"Clin dev immunol"},{"issue":"12","key":"9_CR34","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M et al (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643\u20134649. doi:10.1182\/blood-2005-11-4659","journal-title":"Blood"},{"issue":"2","key":"9_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjh.12011","volume":"159","author":"C Montalban","year":"2012","unstructured":"Montalban C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E et al (2012) Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. Br J Haematol 159(2):164\u2013171. doi:10.1111\/bjh.12011","journal-title":"Br J Haematol"},{"issue":"6","key":"9_CR36","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3109\/10428194.2013.840888","volume":"55","author":"MK Angelopoulou","year":"2014","unstructured":"Angelopoulou MK, Kalpadakis C, Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP (2014) Nodal marginal zone lymphoma. Leuk Lymphoma 55(6):1240\u20131250. doi:10.3109\/10428194.2013.840888","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"9_CR37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","volume":"98","author":"M van den Brand","year":"2013","unstructured":"van den Brand M, van Krieken JH (2013) Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica 98(7):1003\u20131013. doi:10.3324\/haematol.2012.083386","journal-title":"Haematologica"},{"issue":"1","key":"9_CR38","first-page":"92","volume":"26","author":"A Traverse-Glehen","year":"2012","unstructured":"Traverse-Glehen A, Bertoni F, Thieblemont C, Zucca E, Coiffier B, Berger F et al (2012) Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma. Oncology 26(1):92\u201399 103-4","journal-title":"Oncology"},{"issue":"1","key":"9_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1349-7006.2006.00345.x","volume":"98","author":"M Kojima","year":"2007","unstructured":"Kojima M, Inagaki H, Motoori T, Itoh H, Shimizu K, Tamaki Y et al (2007) Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases. Cancer Sci 98(1):44\u201349. doi:10.1111\/j.1349-7006.2006.00345.x","journal-title":"Cancer Sci"},{"issue":"6","key":"9_CR40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","volume":"27","author":"FI Camacho","year":"2003","unstructured":"Camacho FI, Algara P, Mollejo M, Garcia JF, Montalban C, Martinez N et al (2003) Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 27(6):762\u2013771","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/leu.2012.257","volume":"27","author":"N Gachard","year":"2013","unstructured":"Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D et al (2013) IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas. Leukemia 27(1):183\u2013189. doi:10.1038\/leu.2012.257","journal-title":"Leukemia"},{"issue":"11","key":"9_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00277-006-0160-y","volume":"85","author":"SY Oh","year":"2006","unstructured":"Oh SY, Ryoo BY, Kim WS, Kim K, Lee J, Kim HJ et al (2006) Nodal marginal zone B-cell lymphoma: analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma. Ann Hematol 85(11):781\u2013786. doi:10.1007\/s00277-006-0160-y","journal-title":"Ann Hematol"},{"issue":"6","key":"9_CR43","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","volume":"95","author":"F Berger","year":"2000","unstructured":"Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA et al (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95(6):1950\u20131956","journal-title":"Blood"},{"issue":"8","key":"9_CR44","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","volume":"17","author":"BN Nathwani","year":"1999","unstructured":"Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR et al (1999) Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin\u2019s lymphoma classification project. J Clin Oncol 17(8):2486\u20132492","journal-title":"J Clin Oncol"},{"key":"9_CR45","doi-asserted-by":"publisher","unstructured":"Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L (2014) Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematological oncology doi: 10.1002\/hon.2152. [Epub ahead of print, July 22, 2014]","DOI":"10.1002\/hon.2152"},{"issue":"31","key":"9_CR46","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T Wundisch","year":"2005","unstructured":"Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H et al (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23(31):8018\u20138024","journal-title":"J Clin Oncol"},{"issue":"9","key":"9_CR47","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdi277","volume":"16","author":"C Montalban","year":"2005","unstructured":"Montalban C, Santon A, Redondo C, Garcia-Cosio M, Boixeda D, Vazquez-Sequeiros E et al (2005) Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 16(9):1539\u20131544","journal-title":"Ann Oncol"},{"issue":"9","key":"9_CR48","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.bjc.6603708","volume":"96","author":"JS Kim","year":"2007","unstructured":"Kim JS, Chung SJ, Choi YS, Cheon JH, Kim CW, Kim SG et al (2007) Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer 96(9):1324\u20131328","journal-title":"Br J Cancer"},{"issue":"6","key":"9_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","volume":"20","author":"A Stathis","year":"2009","unstructured":"Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L et al (2009) Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 20(6):1086\u20131093. doi:10.1093\/annonc\/mdn760","journal-title":"Ann Oncol"},{"issue":"1","key":"9_CR50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1620\/tjem.214.79","volume":"214","author":"S Terai","year":"2008","unstructured":"Terai S, Iijima K, Kato K, Dairaku N, Suzuki T, Yoshida M et al (2008) Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 214(1):79\u201387","journal-title":"Tohoku J Exp Med"},{"issue":"7","key":"9_CR51","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.dld.2008.09.009","volume":"41","author":"A Andriani","year":"2009","unstructured":"Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M et al (2009) Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis 41(7):467\u2013473. doi:10.1016\/j.dld.2008.09.009 (official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver)","journal-title":"Dig Liver Dis"},{"key":"9_CR52","doi-asserted-by":"publisher","unstructured":"Ruskone-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60(6):747\u201358. doi:10.1136\/gut.2010.224949","DOI":"10.1136\/gut.2010.224949"},{"issue":"1","key":"9_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjh.12078","volume":"160","author":"C Copie-Bergman","year":"2013","unstructured":"Copie-Bergman C, Wotherspoon AC, Capella C, Motta T, Pedrinis E, Pileri SA et al (2013) Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol 160(1):47\u201352. doi:10.1111\/bjh.12078","journal-title":"Br J Haematol"},{"issue":"4","key":"9_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M et al (2012) Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61(4):507\u2013513. doi:10.1136\/gutjnl-2011-300495","journal-title":"Gut"},{"issue":"12","key":"9_CR55","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","volume":"56","author":"W Fischbach","year":"2007","unstructured":"Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wundisch T, Neubauer A, Raderer M et al (2007) Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56(12):1685\u20131687","journal-title":"Gut"},{"issue":"16","key":"9_CR56","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","volume":"44","author":"LG Capelle","year":"2008","unstructured":"Capelle LG, de Vries AC, Looman CW, Casparie MK, Boot H, Meijer GA et al (2008) Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 44(16):2470\u20132476. doi:10.1016\/j.ejca.2008.07.005","journal-title":"Eur J Cancer"},{"issue":"4","key":"9_CR57","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.gastro.2012.06.035","volume":"143","author":"T Wundisch","year":"2012","unstructured":"Wundisch T, Dieckhoff P, Greene B, Thiede C, Wilhelm C, Stolte M et al (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 143(4):936\u2013942. doi:10.1053\/j.gastro.2012.06.035 (quiz e13\u2013e14)","journal-title":"Gastroenterology"},{"issue":"4","key":"9_CR58","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.1997.v113.pm9322502","volume":"113","author":"M Sackmann","year":"1997","unstructured":"Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H et al (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging MALT Lymphoma study group. Gastroenterology 113(4):1087\u20131090","journal-title":"Gastroenterology"},{"issue":"4","key":"9_CR59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.48.4.454","volume":"48","author":"S Nakamura","year":"2001","unstructured":"Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M et al (2001) Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 48(4):454\u2013460","journal-title":"Gut"},{"issue":"3","key":"9_CR60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.48.3.297","volume":"48","author":"A Ruskone-Fourmestraux","year":"2001","unstructured":"Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A et al (2001) Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment. Gut 48(3):297\u2013303","journal-title":"Gut"},{"issue":"2","key":"9_CR61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","volume":"131","author":"G Steinbach","year":"1999","unstructured":"Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM et al (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131(2):88\u201395","journal-title":"Ann Intern Med"},{"issue":"5","key":"9_CR62","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","volume":"122","author":"H Liu","year":"2002","unstructured":"Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122(5):1286\u20131294","journal-title":"Gastroenterology"},{"issue":"18","key":"9_CR63","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","volume":"89","author":"A Neubauer","year":"1997","unstructured":"Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B et al (1997) Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89(18):1350\u20131355","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"9_CR64","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1182\/blood.V95.12.4014","volume":"95","author":"B Alpen","year":"2000","unstructured":"Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E et al (2000) Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95(12):4014\u20134015","journal-title":"Blood"},{"issue":"6","key":"9_CR65","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00280-011-1631-y","volume":"68","author":"SH Kuo","year":"2011","unstructured":"Kuo SH, Cheng AL, Lin CW, Hsu CH, Wu MS, Yeh KH et al (2011) t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. Cancer Chemother Pharmacol 68(6):1387\u20131395. doi:10.1007\/s00280-011-1631-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"22","key":"9_CR66","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","volume":"23","author":"M Levy","year":"2005","unstructured":"Levy M, Copie-Bergman C, Gameiro C, Chaumette MT, Delfau-Larue MH, Haioun C et al (2005) Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 23(22):5061\u20135066","journal-title":"J Clin Oncol"},{"issue":"2","key":"9_CR67","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/10428190903431820","volume":"51","author":"M Levy","year":"2010","unstructured":"Levy M, Copie-Bergman C, Molinier-Frenkel V, Riou A, Haioun C, Gaulard P et al (2010) Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma 51(2):284\u2013290. doi:10.3109\/10428190903431820","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"9_CR68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1042819021000035680","volume":"44","author":"C Thieblemont","year":"2003","unstructured":"Thieblemont C, Dumontet C, Bouafia F, Hequet O, Arnaud P, Espinouse D et al (2003) Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001. Leuk Lymphoma 44(2):257\u2013262","journal-title":"Leuk Lymphoma"},{"issue":"5\u20136","key":"9_CR69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A et al (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26(5\u20136):527\u2013537","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"9_CR70","first-page":"1147","volume":"25","author":"J Yahalom","year":"2011","unstructured":"Yahalom J (2011) Patients with H pylori-independent MALT lymphoma are curable with radiotherapy. Oncology 25(12):1147\u20131149","journal-title":"Oncology"},{"key":"9_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds623","author":"A Wirth","year":"2013","unstructured":"Wirth A, Gospodarowicz M, Aleman BM, Bressel M, Ng A, Chao M et al (2013) Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, international extranodal Lymphoma study group study. Ann Oncol. doi:10.1093\/annonc\/mds623","journal-title":"Ann Oncol"},{"issue":"16","key":"9_CR72","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda JS, Gospodarowicz M, Pintilie M, Wells W, Hodgson DC, Sun A et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116(16):3815\u20133824. doi:10.1002\/cncr.25226","journal-title":"Cancer"},{"issue":"1","key":"9_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.743","volume":"23","author":"RW Tsang","year":"2005","unstructured":"Tsang RW, Gospodarowicz MK (2005) Radiation therapy for localized low-grade non-Hodgkin\u2019s lymphomas. Hematol Oncol 23(1):10\u201317","journal-title":"Hematol Oncol"},{"issue":"28","key":"9_CR74","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J et al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96). J Clin Oncol 23(28):7050\u20137059","journal-title":"J Clin Oncol"},{"issue":"22","key":"9_CR75","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","volume":"21","author":"RW Tsang","year":"2003","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A et al (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21(22):4157\u20134164","journal-title":"J Clin Oncol"},{"issue":"4","key":"9_CR76","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0360-3016(01)02714-6","volume":"52","author":"S Hitchcock","year":"2002","unstructured":"Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM et al (2002) Treatment outcome of mucosa-associated lymphoid tissue\/marginal zone non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys 52(4):1058\u20131066","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"9_CR77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","volume":"52","author":"QT Le","year":"2002","unstructured":"Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, Donaldson SS et al (2002) Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52(3):657\u2013663","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"9_CR78","first-page":"316","volume":"26","author":"SM Ansell","year":"1999","unstructured":"Ansell SM, Grant CS, Habermann TM (1999) Primary thyroid lymphoma. Semin Oncol 26(3):316\u2013323","journal-title":"Semin Oncol"},{"issue":"3","key":"9_CR79","first-page":"357","volume":"26","author":"E Brogi","year":"1999","unstructured":"Brogi E, Harris NL (1999) Lymphomas of the breast: pathology and clinical behavior. Semin Oncol 26(3):357\u2013364","journal-title":"Semin Oncol"},{"issue":"1","key":"9_CR80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000421-200102000-00012","volume":"24","author":"M Agulnik","year":"2001","unstructured":"Agulnik M, Tsang R, Baker MA, Kazdan MS, Fernandes B (2001) Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case report and review of literature. Am J Clin Oncol 24(1):67\u201370","journal-title":"Am J Clin Oncol"},{"issue":"3\u20134","key":"9_CR81","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10428190109058003","volume":"41","author":"S Jhavar","year":"2001","unstructured":"Jhavar S, Agarwal JP, Naresh KN, Shrivastava SK, Borges AM, Dinshaw KA (2001) Primary extranodal mucosa associated lymphoid tissue (MALT) lymphoma of the prostate. Leuk Lymphoma 41(3\u20134):445\u2013449","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"9_CR82","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archotol.126.2.224","volume":"126","author":"BH Suchy","year":"2000","unstructured":"Suchy BH, Wolf SR (2000) Bilateral mucosa-associated lymphoid tissue lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 126(2):224\u2013226","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"9_CR83","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ijrobp.2007.12.007","volume":"71","author":"DR Puri","year":"2008","unstructured":"Puri DR, Tereffe W, Yahalom J (2008) Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. Int J Radiat Oncol Biol Phys 71(5):1425\u20131435. doi:10.1016\/j.ijrobp.2007.12.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"9_CR84","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3109\/10428194.2012.741232","volume":"54","author":"SA Milgrom","year":"2013","unstructured":"Milgrom SA, Yahalom J (2013) Indolent non-Hodgkin lymphoma primarily involving the hard palate: outcome following radiotherapy. Leuk Lymphoma 54(6):1208\u20131211. doi:10.3109\/10428194.2012.741232","journal-title":"Leuk Lymphoma"},{"key":"9_CR85","unstructured":"NCCN National Comprehensive Cancer Network Guidelines (2013) V.2.2013\u2014Non-Hodgkin\u2019s lymphoma. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/nhl.pdf. Accessed 11 Nov 2013"},{"issue":"3","key":"9_CR86","doi-asserted-by":"crossref","first-page":"B100","DOI":"10.1007\/PL00022769","volume":"80","author":"J Yahalom","year":"2001","unstructured":"Yahalom J (2001) MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 80(3):B100\u2013B105","journal-title":"Ann Hematol"},{"key":"9_CR87","unstructured":"Jager G, Hofler G, Linkesch W, Neumeister P (2004) Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica 89(4):ECR01"},{"issue":"10","key":"9_CR88","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/cncr.20237","volume":"100","author":"PL Zinzani","year":"2004","unstructured":"Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A et al (2004) Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100(10):2190\u20132194","journal-title":"Cancer"},{"issue":"8","key":"9_CR89","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F et al (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102(8):2741\u20132745","journal-title":"Blood"},{"issue":"9","key":"9_CR90","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A et al (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s Lymphoma resistant to or not eligible for anti-helicobacter pylori therapy. J Clin Oncol 23(9):1979\u20131983","journal-title":"J Clin Oncol"},{"issue":"S1","key":"9_CR91","first-page":"97","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Martinelli G, Tucci A, Vitolo U, Russo E et al (2013) Chlorambucil plus rituximab produces better event-free and progression-free survival in comparison with chlorambucil or rituximab alone in extranodal marginal zone B-cell lymphoma (MALT lymphoma): results of the IELSG-19 study. Hematol Oncol 31(S1):97\u201398","journal-title":"Hematol Oncol"},{"issue":"5","key":"9_CR92","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B et al (2013) Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol 31(5):565\u2013572. doi:10.1200\/JCO.2011.40.6272","journal-title":"J Clin Oncol"},{"key":"9_CR93","unstructured":"Salar A, Domingo-Domenech E, Panizo C, Nicolas C, Bargay J, A. M et al. (2013) Bendamustine plus rituximab in first line systemic treatment for extranodal MALT lymphoma: final results of phase II trial of the Spanish lymphoma study group (GELTAMO). Hematol oncol 31(S1):129\u2013130"},{"issue":"6","key":"9_CR94","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2141.2009.07677.x","volume":"145","author":"JR Brown","year":"2009","unstructured":"Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P et al (2009) A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol 145(6):741\u2013748. doi:10.1111\/j.1365-2141.2009.07677.x","journal-title":"Br J Haematol"},{"key":"9_CR95","doi-asserted-by":"crossref","unstructured":"Thieblemont C (2005) Clinical presentation and management of marginal zone lymphomas. Hematology (Am Soc Hematol Educ Program) 2005:307\u2013313","DOI":"10.1182\/asheducation-2005.1.307"},{"issue":"8","key":"9_CR96","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","volume":"122","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Raderer M (2013) Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood 122(8):1350\u20131357. doi:10.1182\/blood-2013-02-486522","journal-title":"Blood"},{"issue":"3","key":"9_CR97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1600-0609.2002.01649.x","volume":"68","author":"J van den Bosch","year":"2002","unstructured":"van den Bosch J, Kropman RF, Blok P, Wijermans PW (2002) Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori. Eur J Haematol 68(3):187\u2013188","journal-title":"Eur J Haematol"},{"issue":"1","key":"9_CR98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.46.1.133","volume":"46","author":"M Raderer","year":"2000","unstructured":"Raderer M, Pfeffel F, Pohl G, Mannhalter C, Valencak J, Chott A (2000) Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut 46(1):133\u2013135","journal-title":"Gut"},{"issue":"5","key":"9_CR99","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2141.2003.04170.x","volume":"120","author":"N Arima","year":"2003","unstructured":"Arima N, Tsudo M (2003) Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Haematol 120(5):790\u2013792","journal-title":"Br J Haematol"},{"issue":"9","key":"9_CR100","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1200\/JCO.2005.02.9025","volume":"24","author":"B Grunberger","year":"2006","unstructured":"Grunberger B, Wohrer S, Streubel B, Formanek M, Petkov V, Puespoek A et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24(9):1370\u20131375. doi:10.1200\/JCO.2005.02.9025","journal-title":"J Clin Oncol"},{"key":"9_CR101","doi-asserted-by":"crossref","unstructured":"Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Giordano Resti A, Mazzi B et al. (2005) Regression of ocular adnexal lymphoma following Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 23:5067\u20135073","DOI":"10.1200\/JCO.2005.07.083"},{"issue":"19","key":"9_CR102","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","volume":"98","author":"AJ Ferreri","year":"2006","unstructured":"Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S et al (2006) Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst 98(19):1375\u20131382","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9_CR103","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1349-7006.2010.01502.x","volume":"101","author":"TM Kim","year":"2010","unstructured":"Kim TM, Kim KH, Lee MJ, Jeon YK, Lee SH, Kim DW et al (2010) First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors. Cancer Sci 101(5):1199\u20131203. doi:10.1111\/j.1349-7006.2010.01502.x","journal-title":"Cancer Sci"},{"key":"9_CR104","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-011-0095-9","author":"M Troch","year":"2011","unstructured":"Troch M, Kiesewetter B, Raderer M (2011) Recent developments in nongastric mucosa-associated Lymphoid Tissue Lymphoma. Curr Hematol Malignancy Rep. doi:10.1007\/s11899-011-0095-9","journal-title":"Curr Hematol Malignancy Rep"},{"issue":"7","key":"9_CR105","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3109\/10428194.2013.845884","volume":"55","author":"C Kalpadakis","year":"2014","unstructured":"Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Sachanas S, Angelopoulou MK (2014) Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned? Leuk Lymphoma 55(7):1463\u20131470. doi:10.3109\/10428194.2013.845884","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"9_CR106","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.seminhematol.2010.01.004","volume":"47","author":"M Bennett","year":"2010","unstructured":"Bennett M, Schechter GP (2010) Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Semin Hematol 47(2):143\u2013147. doi:10.1053\/j.seminhematol.2010.01.004","journal-title":"Semin Hematol"},{"issue":"3","key":"9_CR107","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/bjh.12036","volume":"159","author":"M Else","year":"2012","unstructured":"Else M, Marin-Niebla A, de la Cruz F, Batty P, Rios E, Dearden CE et al (2012) Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. Br J Haematol 159(3):322\u2013328. doi:10.1111\/bjh.12036","journal-title":"Br J Haematol"},{"issue":"2","key":"9_CR108","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1634\/theoncologist.2012-0251","volume":"18","author":"C Kalpadakis","year":"2013","unstructured":"Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X et al (2013) Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy. Oncologist 18(2):190\u2013197. doi:10.1634\/theoncologist.2012-0251","journal-title":"Oncologist"},{"issue":"3","key":"9_CR109","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00277-013-1900-4","volume":"93","author":"AJ Olszewski","year":"2014","unstructured":"Olszewski AJ, Ali S (2014) Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma. Ann Hematol 93(3):449\u2013458. doi:10.1007\/s00277-013-1900-4","journal-title":"Ann Hematol"},{"issue":"3","key":"9_CR110","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","volume":"23","author":"D Vallisa","year":"2005","unstructured":"Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R et al (2005) Role of Anti-Hepatitis C Virus (HCV) treatment in HCV-related, low-grade, B-Cell, Non-Hodgkin\u2019s Lymphoma: a multicenter Italian experience. J Clin Oncol 23(3):468\u2013473","journal-title":"J Clin Oncol"},{"key":"9_CR111","doi-asserted-by":"publisher","unstructured":"Arcaini L, Vallisa D, Rattotti S, Ferretti VV, Ferreri AJ, Bernuzzi P et al. (2014) Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol mdu166. doi:10.1093\/annonc\/mdu166","DOI":"10.1093\/annonc\/mdu166"},{"issue":"20","key":"9_CR112","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJMra1213651","volume":"368","author":"TJ Liang","year":"2013","unstructured":"Liang TJ, Ghany MG (2013) Current and future therapies for hepatitis C virus infection. N Engl J Med 368(20):1907\u20131917. doi:10.1056\/NEJMra1213651","journal-title":"N Engl J Med"},{"issue":"21","key":"9_CR113","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMe1403619","volume":"370","author":"TJ Liang","year":"2014","unstructured":"Liang TJ, Ghany MG (2014) Therapy of hepatitis C\u2013back to the future. N Engl J Med 370(21):2043\u20132047. doi:10.1056\/NEJMe1403619","journal-title":"N Engl J Med"},{"issue":"2","key":"9_CR114","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06437.x","volume":"136","author":"L Arcaini","year":"2007","unstructured":"Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F et al (2007) Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol 136(2):301\u2013304. doi:10.1111\/j.1365-2141.2006.06437.x","journal-title":"Br J Haematol"},{"issue":"2","key":"9_CR115","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2559.2005.02309.x","volume":"48","author":"A Traverse-Glehen","year":"2006","unstructured":"Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA et al (2006) A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology 48(2):162\u2013173. doi:10.1111\/j.1365-2559.2005.02309.x","journal-title":"Histopathology"}],"container-title":["Cancer Treatment and Research","Non-Hodgkin Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-13150-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:20:23Z","timestamp":1674192023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-13150-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319131498","9783319131504"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-13150-4_9","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"7 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}